by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized updated COVID-19 shots from Pfizer and Moderna that target the omicron variant for children as young as six months. Children between 6 months and 5 years old who received the Moderna primary series can receive the...
by Jordana Choucair | Dec 9, 2022 | Opioid/Substance Use Disorders
The White House launched a new national dashboard to track non-fatal opioid overdoses and provide first responders, clinicians, and policymakers with real-time, actionable information to improve the country’s response and save lives. The Nonfatal Opioid Overdose...
by Jordana Choucair | Dec 9, 2022 | Payers
A Mercer survey of more than 2,000 companies found that employers expect benefits costs to increase by 5.4 percent next year as health care cost rates catch-up with inflation. Still, most (84 percent) said that “enhancing benefits to improve attraction and...
by Jordana Choucair | Dec 8, 2022 | Access & Coverage
The Centers for Medicare & Medicaid Services (CMS) released new data indicating that 5.5 million people have enrolled in an Affordable Care Act (ACA) marketplace insurance plan in the first five weeks of open enrollment. That figure includes 1.2 million people who...
by Jordana Choucair | Dec 8, 2022 | Health IT
Amazon has ended its support for its HIPAA-compliant Alexa health tool and will delete all of the data by the end of the week. Amazon rolled out the tools on Alexa in 2019, offering applications with a collection of hospitals, as well as telehealth company Teladoc...
by Jordana Choucair | Dec 8, 2022 | Life Sciences
Pfizer and Moderna announced that the commercial prices of their COVID-19 vaccines will likely be between $82 and $130 per dose. The cost is approximately three to four times what the federal government has paid. The Biden administration has started to prepare for the...
Recent Comments